INTRODUCTION
============

An important molecular tool in functional genomics studies is the targeted inactivation of any gene of interest. Ideally, unmarked gene deletions are constructed using a positive selection step for the rare second recombination event. The *sacB* gene of *Bacillus subtilis* is one of the most widely used suicide genes, conferring sucrose sensitivity mostly in Gram-negative bacteria ([@B1],[@B2]). Previously, we reported the use of *sacB* counter-selection to efficiently generate unmarked gene deletions in *Rhodococcus erythropolis* ([@B3]). This method subsequently has been applied in other *Rhodococcus* species ([@B4; @B5; @B6]). Sucrose sensitivity by *sacB* has also been reported for other mycolic acid containing actinobacteria, i.e. *Corynebacterium glutamicum* and *Mycobacterium* sp. ([@B7]). Despite considerable efforts, we have been unable to apply *sacB* as a counter-selectable marker in *Rhodococcus equi*, due to a lack of sucrose sensitivity. Similar observations have been reported for *Streptomyces lividans* ([@B7]). The *sacB* counter-selection system generally is not applicable to other Gram-positive bacteria, like *B. subtilis*. In *B. subtilis*, *mazF*, encoding a toxin, has been used as a suicide marker to generate unmarked gene deletion mutants ([@B8]). This method relies on the availability of a tightly regulated, inducible promoter, limiting applicability in bacteria with less developed molecular toolboxes. The use of alternative suicide genes have been reported as well, e.g. *glkA*, *pyrF*, *upp* and *rpsL* ([@B9; @B10; @B11; @B12]). A major drawback of these markers, however, is that they only function in *glkA, pyrF, upp *or* strA* null mutants, respectively, necessitating the construction, or availability, of a null mutant for every strain to be mutated. A PCR-targeted gene replacement strategy has been reported for streptomycetes that relies on the availability of ordered genomic libraries to efficiently generate mutants ([@B13]). This method, however, requires a laborious extra round of mutagenesis to remove the resistance marker integrated into the genome to generate unmarked mutants. Recently, a simplified method for marker removal in actinomycetes using Flp recombinase has been described ([@B14]).

Cytosine deaminase (CD, EC 3.5.4.5) and uracil phosphoribosyltransferase (UPRT, EC 2.4.2.9) are enzymes involved in the pyrimidine salvage pathway, converting cytosine via uracil into dUMP. CD activity has been found in certain prokaryotes and lower eukaryotes. The genes encoding these activities in *Escherichia coli*, *codA* and *upp*, respectively, have been cloned and characterized ([@B15],[@B16]). Interestingly, microorganisms expressing CD convert the innocuous cytosine analog 5-fluorocytosine (5-FC) into 5-fluorouracil (5-FU), a highly toxic compound lethal to living cells. The cytotoxicity is largely exerted following UPRT mediated conversion of 5-FU into 5-fluoro-dUMP, which irreversibly inactivates thymidylate synthase inhibiting both RNA and DNA synthesis ([@B17]). Heterologous expression of *E. coli codA* was shown to confer 5-FC sensitivity to mammalian cells, ordinarily not producing CD ([@B18]). Concomitant expression of *E. coli* CD and UPRT as a fusion protein, encoded by *codA*::*upp*, was shown to further enhance the 5-FC cytotoxicity ([@B19]). A recent study on pyrimidine salvage in *Streptomyces* species indicated a lack of CD activity but sensitivity towards 5-FU ([@B20]). Some other actinobacteria, like *Rhodococcus* species, were also shown to be 5-FU sensitive ([@B21],[@B22]). Most *Nocardia* species and certain *Mycobacterium* strains, however, were 5-FU resistant, while other mycobacteria strains were highly 5-FU sensitive ([@B21]).

*R. equi* is a facultative intracellular pathogen that causes fatal pyogranulomatous bronchopneumonia in young foals. It is also an emerging opportunistic pathogen of immuno-compromised humans, particularly HIV infected patients ([@B23],[@B24]). In addition to its pathogenic life-style, *R. equi* is a common soil-dwelling microorganism capable of rapid growth in soil and manure, using plant and animal sterols as sole carbon and energy sources ([@B25],[@B26]). Knowledge on sterol metabolism in *R. equi* is extremely limited. So far, only the gene encoding the proposed first step in cholesterol degradation, cholesterol oxidase (*choE*), has been identified and inactivated in *R. equi* ([@B27],[@B28]). A cholesterol catabolic gene cluster has been identified in the closely related *Rhodococcus jostii* RHA1 ([@B6],[@B29]). This cluster also encodes a putative cholesterol uptake system, designated *mce4* operon. 'Mammalian cell entry' (*mce*) genes are critical virulence factors of the intracellular pathogen *Mycobacterium tuberculosis* ([@B30]) and, interestingly, *mce1*^−^ and *mce4*^−^ strains of *M. tuberculosis* H37Rv showed attenuated survival in mice ([@B31]). The *supAB* genes are part of the *mce4* operon and may encode the permease subunits of the cholesterol uptake system ([@B6]). The *supAB* and *mce4* genes were shown to be essential for growth of *R. jostii* RHA1 on cholesterol ([@B6]). Pandey and Sassetti ([@B32]) recently confirmed that cholesterol is used as a carbon and energy source by *M. tuberculosis* H37Rv, and that the *mce4* cluster in H37Rv is essential for growth on cholesterol.

The *R. equi* strain 103S genome sequence recently has become available (<http://www.sanger.ac.uk/Projects/R_equi/>). Proper genome annotation and identification of pathogenicity genes requires simple methods for gene deletion mutagenesis. A method for the isolation of gene deletion mutants of *R. equi* by the double homologous recombination strategy was first reported by Navas *et al*. ([@B27]). An improved method, using *lacZ* as counter-selectable marker, was subsequently reported by Jain *et al*. ([@B33]). These methods, however, often involve screening and handling of large numbers of colonies to select for the rare second recombination event ([@B34],[@B35]). Here we show that introduction of the *codA*::*upp* cassette confers 5-FC sensitivity to *R. equi* allowing positive selection of the targeted gene deletion mutants. A simple and efficient procedure to generate unmarked in-frame gene deletions in *R. equi* is reported, exemplified by the construction and characterization of a Δ*supAB* mutant.

MATERIALS AND METHODS
=====================

Culture media and growth conditions for *R. equi* strain RE1
------------------------------------------------------------

Virulent *R. equi* wild type strain RE1 was isolated from a foal with pyogranulomatous pneumonia in September 2007 in The Netherlands. *R. equi* strains were grown at 30°C (200 r.p.m.) in Luria-Bertani (LB) medium or mineral acetate medium (MM-Ac). MM-Ac contained K~2~HPO~4~ (4.65 g/l), NaH~2~PO~4~ · H~2~O (1.5 g/l), sodium-acetate (2 g/l), NH~4~Cl (3 g/l), MgSO~4~ · 7H~2~O (1 g/l), thiamine (40 mg/l, filter sterile) and Vishniac stock solution (1 ml/l). Vishniac stock solution was prepared as follows \[modified from ([@B36])\]: EDTA (10 g/l) and ZnSO~4~ · 7H~2~O (4.4 g/l) were dissolved in distilled water (pH 8 using 2 M KOH). Then, CaCl~2~ċ2H~2~O (1.47 g/l), MnCl~2~ċ7 H~2~O (1 g/l), FeSO~4~ċ7H~2~O (1 g/l), (NH~4~)~6~ Mo~7~O~24~ċ4 H~2~O (0.22 g/l), CuSO~4~ċ5H~2~O (0.315 g/l) and CoCl~2~ċ6 H~2~O (0.32 g/l) were added in that order at pH 6 and finally stored at pH 4. For growth on solid media Bacto-agar (15 g/l) was added. 5-Fluorocytosine (Sigma-Aldrich Chemie, Zwijndrecht, The Netherlands) and 5-fluorouracil (Sigma-Aldrich) stock solutions (10 mg/ml) were prepared in distilled water, dissolved by heating to 50°C, filter-sterilized and added to autoclaved media.

For growth on cholesterol, *R. equi* strains were inoculated in 25 ml MM-Ac liquid medium and grown for 24 h at 200 r.p.m. and 30°C. The pre-culture (0.5 ml) was used to inoculate 50 ml of MM medium containing 0.5 g/l cholesterol (Sigma-Aldrich) as sole carbon and energy source which had been finely dispersed by sonication. Regular turbidity (OD~600nm~) measurements of cholesterol grown cultures were not possible due to high background of the cholesterol suspension. Protein content of the culture was used as a measure for biomass formation and was determined as follows. A sample (0.5 ml) of the culture was pelleted by centrifugation (5 min at 12 000*g*) and thoroughly resuspended in 0.1 ml Bacterial Protein Extraction Reagent (B-PER, Pierce, PerBio Science Nederland B.V., Etten-Leur, The Netherlands). Then, 0.4 ml distilled water was added and the suspension was vortexed and incubated at room temperature for 5--10 min. An aliquot of 160 μl was mixed with 640 μl of distilled water and 200 μl of protein assay reagent (BioRad) was added. Protein content of the sample was determined using bovine serum albumin (BSA) as a standard as described by the manufacturer.

Cloning, PCR and chromosomal DNA isolation
------------------------------------------

*E. coli* DH5α was used as host for all cloning procedures. Restriction enzymes were obtained from Fermentas GmbH (St Leon-Rot, Germany). PCR was performed in a reaction mixture (25 μl) consisting of Tris--HCl (10 mM, pH 8), 10 × High-Fidelity polymerase buffer (Fermentas), dNTPs (0.2 mM), DMSO (2%), PCR primers (10 ng/μl each, [Table 1](#T1){ref-type="table"}) and High-Fidelity polymerase enzyme (1--2 U, Fermentas). For colony PCR, cell material was mixed with 100 µl of chloroform and 100 µl of 10 mM Tris--HCl pH 8, vortexed vigorously and centrifuged (2 min at 14 000*g*). A sample of the upper water phase (1 μl) was subsequently used as template for PCR. Chromosomal DNA of *R. equi* cell cultures was isolated using the GenElute Bacterial Genomics DNA Kit (Sigma-Aldrich) according to the instructions of the manufacturer. Table 1.Oligonucleotides used in this studyNoPCR ampliconSize (bp)Oligonucleotide sequence (nr.)1Upstream region *supAB* (deletion construct)1592supABequiUP-F ATCGCGAGGTCAGCTTGGAG ([@B1]) supABequiUP-R CCCGGGCGCCGACATCGCGAAGAATC ([@B2])2Downstream region *supAB* (deletion construct)1470supABequiDOWN-F CCCGGGCTCATCCACACCTACTACGG ([@B3]) supABequiDOWN-R ACTAGTGAGCTGCTGAATCTGAACTGG ([@B4])3Upstream region *supAB* (confirmation deletion mutant)1786 (wt: 3192)supABequiContrUP-F CGGGAGTGCGTAGATGAGTGCA ([@B5]) supABequiContr-R TTATCCCGAAAGGTTGAAGTTG ([@B6])4Downstream region *supAB* (confirmation deletion mutant)1570 (wt: 2976)supABequiContr-F GTGGTCGACCTCCTCGAGGTAC ([@B7]) supABequiContrDOWN-R GGACTTGAGCCCGGAGGCATCG ([@B8])5*supAB* genes (confirmation deletion mutant)231 (wt: 1637)supABequiContr-F GTGGTCGACCTCCTCGAGGTAC ([@B7]) supABequiContr-R TTATCCCGAAAGGTTGAAGTTG ([@B6])6*supAB* genes (complementation Δ*supAB* mutant)3163supABequiUP-F ATCGCGAGGTCAGCTTGGAG ([@B1]) supABequiContr-R TTATCCCGAAAGGTTGAAGTTG ([@B6])7*aphII* promoter region367Pkan-F AGCTTCACGCTGCCGCAAGCACT Pkan-E5-R GATATCATGCGAAACGATCCTCATCCTG8*Pkan-codA* cassette1733Pkan-F AGCTTCACGCTGCCGCAAGCACT codA-R2 GTCAACGTTTGTAATCGATGGCTTCT9*vapA*408vapA-F GCAGCAGTGCGATTCTCAATAG ([@B9]) vapA-R TAACTCCACCGGACTGGATATG ([@B10])[^2]

Electrotransformation of *R. equi* strain RE1
---------------------------------------------

*R. equi* strain RE1 cells were transformed by electroporation essentially as described ([@B27]). Briefly, cell cultures were grown in 50 ml LB at 30°C until OD~600~ reached 0.8--1.0. The cells were pelleted (20 min at 4500*g*) and washed twice with 10% ice-cold glycerol. Pelleted cells were re-suspended in 0.5--1 ml ice-cold 10% glycerol and 200 μl aliquots were put on ice. MilliQ-eluted plasmid DNA (5--10 μl; GenElute Plasmid Miniprep Kit, Sigma-Aldrich) was added to 200 μl cells in 2 mm gapped cuvettes. Electroporation was performed with a single pulse of 12.5 kV/cm, 1000 Ω and 25 μF. Electroporated cells were gently mixed with 1 ml LB medium and allowed to recover for 2 h at 37°C and 200 r.p.m. Aliquots (200 μl) were plated onto LB agar medium containing apramycin (50 μg/ml; Duchefa Biochemie, Haarlem, The Netherlands). Transformants appeared after 2--3 days of incubation at 30°C. The transformation efficiency for non-replicative plasmids integrating via homologous recombination was ∼ 10 transformants/μg plasmid DNA.

5-Fluorocytosine positive selection in *R. equi*
------------------------------------------------

*R. equi* transformants were inoculated in LB liquid medium (25 ml) and grown overnight (20--24 h) at 30°C and 200 r.p.m. 5-FC selection was performed by plating 100 μl aliquots of a dilution series (10^−1^ to 10^−3^ in MM-Ac medium) of the grown culture onto MM-Ac agar plates supplemented with 5-FC (100 μg/ml). Dilution of the culture prior to plating was crucial for effective 5-FC selection. 5-FC resistant colonies appeared after 2--3 days of incubation at 30°C.

Construction of plasmids pSET-Pkan-codA, pSET-Pkan-codAupp and pSelAct
----------------------------------------------------------------------

The *aphII* promoter region was amplified from pRESQ ([@B37]) using PCR primers Pkan-F and Pkan-E5-R ([Table 1](#T1){ref-type="table"}). The obtained PCR product of 367 bp was blunt-ligated into *Eco*RV digested pBluescript(II)KS (Stratagene), resulting in pBs-Pkan. A *Sal*I/*Not*I restriction released a 431 bp fragment comprising the *aphII* promoter which was then cloned into *Sal*I/*Not*I digested pORF-codA::upp (InvivoGen, San Diego, USA), yielding plasmid pORF-Pkan-codAupp. The Pkan-codA::upp cassette was subsequently isolated from pORF-Pkan-codAupp as a 2.4 kb *Sma*I/*Nhe*I fragment and ligated into *Eco*RV/*Xba*I digested pSET152 resulting in plasmid pSET-Pkan-codAupp ([Figure 2](#F2){ref-type="fig"}). The Pkan-codA cassette (1733 bp) was amplified from pSET-Pkan-codAupp using primers Pkan-F and codA-R2 ([Table 1](#T1){ref-type="table"}) and ligated into *Eco*RV digested pSET152, resulting in pSET-Pkan-codA ([Figure 2](#F2){ref-type="fig"}). Suicide plasmid pSelAct ([Figure 3](#F3){ref-type="fig"}) was constructed by ligating a 2.4 kb Klenow-treated *Eco*RI/*Nhe*I fragment of pORF-Pkan-codAupp into *Ssp*I digested pBs-Apra-ori dephosphoryated with alkaline phosphatase. Plasmid pBs-Apra-ori was constructed from pBluescript(II)KS in which the *bla* cassette was removed with *Bsp*HI, followed by Klenow treatment and replaced by an apramycin-*oriT* cassette obtained as a 1.3 kb *Xba*I fragment (Klenow treated) from pIJ773 ([@B13]). Figure 1.Introduction of *E. coli codA*::*upp* cassette, encoding CD and UPRT, confers 5-FC sensitivity to *R. equi* strain RE1. Panels show wild type strain RE1, recombinant strain RE1 containing pSET152, recombinant strain RE1 containing plasmid pSET-codA::upp streaked on mineral acetate agar (MM-Ac) containing (**A**) no addition, (**B**) 5-FC (100 μg/ml) or (**C**) 5-FU (50 μg/ml) and on (**D**) LB agar containing 5-FC (100 μg/ml). Figure 2.The pSET152 derived integrative plasmids used to introduce the (**A**) *codA* or (**B**) *codA*::*upp* cassette into *R. equi* RE1, expressed under control of the *aphII* kanamycin resistance cassette promoter (P*~aphII~*). The apramycin resistance cassette (*aac(3*)*IV*), the *Streptomyces* PhiC31 integrase gene (*int*) and the RP4 origin of transfer (*ori*T) are also indicated. Figure 3.Schematic representation of the non-replicative plasmid pSelAct used to generate unmarked in-frame gene deletions in *R. equi* RE1. Restriction sites indicated are unique.

Macrophage survival test
------------------------

The human monocyte cell line U937 ([@B38]) was used to test for survival of *R. equi* strains. The monocytes were grown in RPMI 1640 (Invitrogen) + NaHCO~3~ (1 g/l) + sodium pyruvate (0.11 g/l) + glucose medium (4.5 g/l) (RPMI 1640 medium), buffered with 10 mM HEPES (Hopax fine chemicals, Taiwan) and supplemented with penicillin (200 IU/ml), streptomycin (200 IU/ml) and 10% fetal bovine serum (FBS). The cells were grown in suspension at 37°C and 5% CO~2~. For the macrophage survival assay, monocytes were grown for several days as described above. The culture medium was replaced with fresh culture medium and the cells were activated overnight with phorbol 12-myristate 13-acetate (60 ng/ml, PMA, Sigma-Aldrich) to induce their differentiation to macrophages. The differentiated cells were spun down (5 min at 200*g*) and the pellet was re-suspended in fresh, antibiotic free RPMI 1640 medium with 10% FBS. For each strain to be tested, a tube containing 10 ml of a cell suspension (∼10^6^ cells/ml) was inoculated with *R. equi*, pre-grown in nutrient broth (Difco, Detroit, MI., USA) at 37°C, at a multiplicity of infection (MOI) of approximately 10 bacteria per macrophage. The bacteria were incubated with the macrophages for 1 h at 37°C and 5% CO~2~. The medium was replaced with 10 ml RPMI 1640 medium supplemented with 10% FBS and 100 µg/ml gentamycin and incubated again for 1 h to kill any extra-cellular bacteria. The macrophages (with internalized *R. equi*) were spun down (5 min at 200*g*) and the pellet was re-suspended in 40 ml RPMI 1640 medium, buffered with 10 mM HEPES and supplemented with 10% FBS and gentamycin (10 µg/ml). This suspension was divided over four culture bottles (10 ml each) and incubated at 37°C and 5% CO~2~. After 4, 28, 52 and 76 h the macrophages (one culture bottle per strain) were spun down (5 min at 200*g*) and the pellet washed twice in 1 ml antibiotic free RPMI 1640 medium. Finally the pellet was lysed with 1% Triton X-100 (Sigma-Aldrich) in 0.01 M phosphate buffered saline, followed by live count determination (plate counting).

Culture media and growth conditions for 5-FC selection in actinobacteria
------------------------------------------------------------------------

Actinobacterial strains ([Table 2](#T2){ref-type="table"}) were grown until late exponential phase as shaken liquid cultures in complex medium at 30°C, except for *Amycolatopsis methanolica* and *Mycobacterium smegmatis* which were grown at 37°C. Tryptic Soy Broth (TSB) was used for *Corynebacterium glutamicum*, *Arthrobacter globiformis*, *Amycolatopsis orientalis*, *A. methanolica* and *M. smegmatis*. TSB supplemented with 2.5% NaCl was used for *Salinospora tropica*, and YEME:TSB (1:1) ([@B39]) for all *Streptomyces* strains and *Saccharopolyspora erythrea*. LB was used for *R. equi* and *Rhodococcus rhodochrous* and LBP ([@B3]) was used for *R*. *erythropolis* and *R. jostii*. Minimal regeneration medium (MRM) consisted of K~2~SO~4~ (0.25 g/l), (NH~4~)~2~SO~4~ (2 g/l), MgCl~2~ċ6H~2~0 (0.6 g/l), 2-\[(hydroxyl-1, 1-bis (hydroxymethyl)ethyl)amino\] ethanesulfonic acid; TES (5.73 g/l) and trace elements ([@B39]). Sucrose (10.3% w/v) and [l]{.smallcaps}-proline (0.3% w/v) were added to MRM medium for *Streptomyces* strains, but omitted for all other strains. Glucose (20 mM) was used as carbon and energy source, except for all *Rhodococcus* strains which were grown in the presence of acetate (2 g/l). Autoclaved MRM was supplemented with KH~2~PO~4~ (0.1 g/l), CaCl~2~ċ2H~2~0 (3 g/l) and NaOH (0.28 g/l). For agar plates 2% granulated agar was added. Filter-sterilized thiamine (40 μg/ml) was added to autoclaved MRM medium for growth of *Rhodococcus* strains. 5-FC and 5-FU were freshly prepared as 10 mg/ml stocks in distilled water, dissolved by heating to 50°C and added to autoclaved medium. Table 2.Growth of actinobacteria on MRM mineral agar media supplemented with different concentrations of 5-FC or 5-FUStrain5-FC (μg/ml)5-FU (μg/ml)Reference/origin020501002050100*Amycolatopsis methanolica* NCIB11946+++−−------([@B44])*Amycolatopsis orientalis* ATCC 19795++++++−−−ATCC*Arthrobacter globiformis* DSM 20124++++++------DSMZ*Corynebacterium glutamicum* ATCC 13032+++−−−----ATCC*Mycobacterium smegmatis* mc^2^155+++−−------([@B45])*Rhodococcus rhodochrous* DSM 43269+++++++++----DSMZ*Rhodococcus erythropolis* SQ1++++++++------([@B46])*Rhodococcus jostii RHA1*+++++++++−--M. Fukuda, Nagaoka (Japan)*Rhodococcus equi* RE1+++++++++----Schering-Plough, Netherlands*Salinospora tropica*++++++++−−−DSMZ*Saccharopolyspora erythraea*++++++++------DSMZ*Streptomyces albus* J1074++++++++------([@B47])*Streptomyces avermitilis* MA-4680++++++++++++++ATCC (ATCC 31267)*Streptomyces coelicolor* M145++++++++------([@B39])*Streptomyces griseus* DSM40236++++++++------DSMZ*Streptomyces lividans* TK23++++++++------([@B39])*Streptomyces scabies* ISP5078+++++++------Wellington, Warwick (UK)*Streptomyces tendae* Tü 901/8c++++++++----([@B48])[^3][^4]

RESULTS AND DISCUSSION
======================

CD-UPRT mediated 5-fluorocytosine sensitivity of *R. equi* strain RE1
---------------------------------------------------------------------

An obvious prerequisite for the applicability of a 5-FC based conditionally lethal positive selection system is natural resistance of *R. equi* strain RE1 towards 5-FC. To test this, *R. equi* RE1 was streaked onto acetate mineral (MM-Ac) agar plates supplemented with 5-FC or 5-FU and incubated for 3 days at 30°C. Examination of the plates revealed that *R. equi* was resistant to high concentrations of 5-FC (100 μg/ml), but highly sensitive to a lower concentration of 5-FU (50 μg/ml), indicating the feasibility of developing a 5-FC based positive selection system for *R. equi* ([Figure 1](#F1){ref-type="fig"}). Next, we examined whether expression of the *E. coli* genes *codA* and *upp* in *R. equi* would confer sensitivity to 5-FC and thus could act as a suicide marker. The integrative *E. coli*-*Streptomyces* shuttle vector pSET152 provided a stable and convenient vehicle to introduce *codA* or a functional *codA*::*upp* fusion into the *R. equi* genome ([@B40],[@B41]). The *aphII* promoter region of the kanamycin resistance cassette (Pkan) was used to drive expression of *codA* or *codA*::*upp*, respectively. The two resulting integrative plasmids, pSET-Pkan-codA and pSET-Pkan-codAupp ([Figure 2](#F2){ref-type="fig"}), were mobilized separately by electroporation to *R. equi* RE1. Transformants harboring either pSET-Pkan-codA or pSET-Pkan-codAupp were streaked onto MM-Ac agar plates ([Figure 1](#F1){ref-type="fig"}A), MM-Ac agar plates supplemented with 100 μg/ml 5-FC ([Figure 1](#F1){ref-type="fig"}B), or MM-Ac agar plates supplemented with 50 μg/ml 5-FU ([Figure 1](#F1){ref-type="fig"}C) and incubated for 3 days at 30°C. The presence of the *codA*::*upp* cassette rendered *R. equi* sensitive to 5-FC, whereas expression of *codA* alone did not result in 5-FC sensitivity ([Figure 1](#F1){ref-type="fig"}B). Growth of the *R. equi* strain carrying the *codA*::*upp* cassette under nonselective conditions was similar to that of wild type ([Figure 1](#F1){ref-type="fig"}A), indicating that expression is conditionally lethal and not detrimental to cells when 5-FC is omitted from the medium. Importantly, no 5-FC selection was observed when complex agar media (LB) was used ([Figure 1](#F1){ref-type="fig"}D). This may be due to repression of the pyrimidine salvage pathway affecting 5-FC uptake.

To enable the generation of unmarked in-frame gene deletions in *R. equi* using CD-UPRT based 5-FC conditional lethality, we next developed a non-replicative suicide vector designated pSelAct ([Figure 3](#F3){ref-type="fig"}; see Materials and Methods section). Vector pSelAct is a small (5.6 kb) conjugative plasmid based on pBlueScript(II)KS, harboring the *aac*(*3*)*IV* cassette for apramycin resistance that can be used both in *E. coli* and *R. equi*. The vector contains a MCS with several unique restriction sites for cloning flanking regions of the gene of interest using *lacZ* dependent blue-white screening in *E. coli*.

Unmarked in-frame gene deletion of *supAB* in *R. equi*
-------------------------------------------------------

A BLAST search with the *supA* (*ro04696*), *supB* (*ro04697*) and *mce4* (*ro04698*-*ro04703*) genes of *R. jostii* RHA1, predicted to encode the cholesterol uptake machinery ([@B6]), revealed that these genes and their apparent operonic organization were highly conserved in the *R. equi* 103S genome ([Figure 4](#F4){ref-type="fig"}; <http://www.sanger.ac.uk/Projects/R_equi/>). Highest amino acid identities were observed for SupA (94%) and SupB (89%), whereas the *mce4* encoded proteins Mce4A-Mce4F showed lower identities (57--71%) ([Figure 4](#F4){ref-type="fig"}). Figure 4.(**A**) Schematic overview of the molecular organization of the *mce4* gene clusters in *R. jostii* RHA1 and *R. equi* 103S. Percentages indicate amino acid sequence identities between the Mce4 proteins of *R. jostii* RHA1 and *R. equi* RE1. (**B**) Construction of mutagenic plasmid pSelAct-Δ*supAB* used to generate an unmarked *supAB* gene deletion mutant of *R. equi* RE1. Small black arrows with numbers indicate the PCR oligonucleotides used in this study ([Table 1](#T1){ref-type="table"}) and the site of their annealing. (**C**) Molecular organization of the *mce4* locus of *R. equi* RE1 following integration of pSelAct-ΔsupAB by single homologous recombination, and second homologous recombinant event after 5-FC counter-selection, resulting in *supAB* gene deletion.

The *supA* and *supB* genes are the first two genes of the *mce4* operon, and may encode the cholesterol permease subunits ([Figure 4](#F4){ref-type="fig"}). To demonstrate a specific role of *supAB* in cholesterol catabolism, we aimed for their selective inactivation, without affecting expression of the downstream genes. This prompted us to develop the unmarked in-frame gene deletion system for *R. equi* based on counter-selection with 5-FC. The upstream and downstream flanking regions (∼1.5 kb) of the *supAB* genes were amplified by PCR and ligated into pSelAct generating pSelAct-Δ*supAB* ([Figure 4](#F4){ref-type="fig"}; [Table 1](#T1){ref-type="table"} for primers). This construct was used to generate a Δ*supAB* mutant, by reducing the wild type *supA* (765 nt) and *supB* (852 nt) genes, encompassing 1637 bp, to a single in-frame open-reading-frame of 231 bp, encoding the first 20 amino acid of SupA and the last 54 amino acids of SupB, separated by a 6 bp *Sma*I restriction site. The first and last part of *supA* and *supB*, respectively, were left intact to ensure proper expression of downstream genes in the *mce4* operon. Introduction of plasmid pSelAct-Δ*supAB* into *R. equi* RE1, selecting for apramycin resistance, resulted in 29 transformants of which four were selected and grown nonselectively overnight for 20 h in LB medium (i.e. lacking apramycin and 5-FC). Aliquots (100 μl) of the overnight cultures were plated in 10^−1^ to 10^−3^ dilutions onto MM-Ac agar plates supplemented with 100 μg/ml 5-FC and incubated for 3 days at 30°C. Confluent growth on 5-FC selection plates was obtained for one of the transformants. Conceivably, the *codA*::*upp* suicide cassette had been inactivated in this transformant by spontaneous mutation or transposon insertion, as has been reported to occur during *sacB* counter-selection ([@B3],[@B42]). Typically, \>10^2^ colonies grew on the 10^−2^ plate from which 50 colonies were replica picked onto LB agar with and without apramycin to select for 5-FC^R^/Apra^S^ colonies. The frequency of 5-FC^R^/Apra^S^ colonies amongst the other three transformants varied between 70--90%, indicating that the suicide cassette had been inactivated in 10--30% of the 5-FC^R^/Apra^S^ colonies. For one transformant, eighteen 5-FC^R^/Apra^S^ colonies were checked by colony PCR for the presence of the mutant Δ*supAB* genotype using PCR with oligonucleotides 6 and 7 amplifying the *supAB* genes ([Table 1](#T1){ref-type="table"}, [Figure 4](#F4){ref-type="fig"}). Two of the eighteen FC^R^/Apra^S^ colonies gave a PCR product of the expected size (231 bp) and were selected for further characterization. Genomic DNA was isolated from these two Δ*supAB* mutants and subjected to PCR analysis of the *supAB* locus and the up- and downstream flanking regions of *supAB* ([Figure 5](#F5){ref-type="fig"}, see [Table 1](#T1){ref-type="table"} for oligonucleotides used). This confirmed the presence of a genuine *supAB* gene deletion in both cases and revealed no aberrant genomic rearrangements at the *supAB* locus ([Figure 5](#F5){ref-type="fig"}). One mutant strain was chosen, designated *R. equi* RE1Δ*supAB*, and was used for further characterization. Figure 5.PCR analysis of wild type *R. equi* strain RE1 (wt) and two Δ*supAB* gene deletion mutants of *R. equi* strain RE1 (1 and 2). Panels show amplification of (I) the *supAB* locus \[6 + 7\], (II) the upstream region of *supAB* \[5 + 6\], (III) the downstream region of *supAB* \[7 + 8\], (IV) the *vapA* virulence gene \[9 + 10\]. The oligonucleotides used are mentioned between brackets and described in [Table 1](#T1){ref-type="table"} and/or [Figure 4](#F4){ref-type="fig"}.

Phenotypical analysis and functional complementation of *R. equi* RE1ΔsupAB mutant
----------------------------------------------------------------------------------

*R. equi* RE1 wild type and the RE1Δ*supAB* mutant strain were grown in MM-Ac liquid medium and used to inoculate MM-cholesterol liquid medium. The RE1Δ*supAB* mutant was completely blocked in growth on cholesterol as sole carbon and energy source ([Figure 6](#F6){ref-type="fig"}). Growth on acetate or the steroid substrate 4-androstene-3,17-dione (AD) was unaffected and comparable to the wild type strain (data not shown). This indicated that *supAB* are essential for cholesterol catabolism, probably acting as the permease subunits of the cholesterol ABC transporter. These results are fully consistent with the phenotype of the *supAB* mutant of strain RHA1 ([@B6]). Figure 6.Growth curves in mineral medium supplemented with cholesterol (0.5 g/l) of *R. equi* RE1 wild-type (filled diamond), RE1 Δ*supAB* mutant strain (filled square), RE1 Δ*supAB* + pSET-supAB complemented strain (filled triangle), and RE1 Δ*supAB* + pSET152 control strain (x). Protein content (mg/l) of the culture was used as a measure for biomass formation. The data represent the averages for two independent experiments.

To ensure that the growth deficiency of the RE1Δ*supAB* mutant was solely due to deletion of the *supAB* genes, a 3163-bp DNA fragment carrying the wild-type *supAB* genes was introduced by electroporation into the RE1Δ*supAB* mutant. The DNA fragment was obtained by PCR on strain RE1 wild type DNA using oligonucleotides 1 and 6 ([Table 1](#T1){ref-type="table"}, [Figure 4](#F4){ref-type="fig"}) and cloned into the integrative plasmid SET152, resulting in pSET-supAB. The cholesterol growth negative phenotype of the RE1Δ*supAB* mutant harboring pSET-supAB was fully complemented, restoring growth on cholesterol to levels comparable to the wild type ([Figure 6](#F6){ref-type="fig"}). We conclude that the *supAB* deletion did not exert any polar effects on the expression of other genes in the *mce4* operon.

These data show that we have developed a novel, simple and efficient method to generate unmarked in-frame gene deletions in *R. equi*, based on 5-FC lethality in the presence of the *E. coli codA*::*upp* fusion gene.

Deletion of *supAB* does not affect *R. equi* RE1 survival in macrophages
-------------------------------------------------------------------------

Intracellular survival and proliferation of the *R. equi* RE1Δ*supAB* mutant in the human monocyte cell line U937 was compared to those of wild type strain RE1 ([Figure 7](#F7){ref-type="fig"}). The avirulent, plasmid free strain *R. equi* 103^−^ ([@B43]) was included as a negative control for macrophage survival ([Figure 7](#F7){ref-type="fig"}). The results revealed that the RE1Δ*supAB* mutant is able to survive and proliferate in macrophages comparable to the wild-type parent strain RE1. By contrast, the avirulent strain 103^−^ failed to proliferate, resulting in reduced numbers of intracellular bacteria in time ([Figure 7](#F7){ref-type="fig"}). These results indicate that cholesterol metabolism is not essential for macrophage survival of *R. equi* RE1 and suggest that cholesterol metabolism is not important for virulence of *R. equi* RE1 *in vivo*. These observations are consistent with the finding that ChoE is not important in the virulence of *R. equi* ([@B28]). Figure 7.Survival and proliferation of *R. equi* strains in the human monocyte cell line U937. Macrophage cell suspensions were infected with wild type virulent strain *R. equi* RE1 (filled diamond), mutant strain *R. equi* RE1Δ*supAB* (filled square) and non-virulent (control) strain *R. equi* 103^−^ (filled triangle). Following a 1-h incubation to allow phagocytosis, cells were washed and treated with gentamycin to kill remaining extra-cellular bacteria. The numbers of intracellular bacteria were determined by plate counts following macrophage lysis. The data represent the averages for two independent experiments. Plate counts were carried out in duplicate.

Actinobacteria are generally 5-FC resistant
-------------------------------------------

The CD-UPRT based 5-FC selection could also be a useful asset in the generation of unmarked in-frame gene deletions in other actinobacteria. To examine whether CD-UPRT selection potentially is an effective counter-selectable marker in this family of microorganisms, we tested the sensitivity of several actinobacteria towards 5-FC and 5-FU. A wide selection of actinobacterial strains were grown in complex medium until late exponential/early stationary phase and plated in 10-fold dilutions onto mineral selection media containing increasing concentrations of 5-FC or 5-FU ([Table 2](#T2){ref-type="table"}). The tested strains generally were resistant to high concentrations of 5-FC (100 μg/ml), but highly sensitive to lower concentrations of 5-FU (20--50 μg/ml), indicating the feasibility of developing a 5-FC based positive selection system for other actinobacteria.
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[^1]: The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
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[^3]: Symbols indicate growth (++), moderate growth (+), slight/minor growth (−) or no growth (--).

[^4]: ATCC, American Type Culture Collection; DSMZ, Deutsche Sammlung von Mikroorganismen und Zellkulturen.
